|Bid||0.00 x 800|
|Ask||0.00 x 1000|
|Day's Range||46.13 - 48.99|
|52 Week Range||36.03 - 61.00|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 07, 2022 - Mar 11, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||63.80|
Subscribe to Yahoo Finance Plus to view Fair Value for OMLearn more
SAN JOSE, Calif., November 29, 2021--Outset Medical's Tablo® Hemodialysis System cartridge receives FDA 510(k) clearance enabling production in North America.
SAN JOSE, Calif., November 18, 2021--Outset Medical, a medical technology focused on changing the dialysis industry, has been named to Fast Company’s Next Big Things in Tech list
The consensus price target hints at a 27.4% upside potential for Outset Medical, Inc. (OM). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.